NEW PARTNERSHIP POSITIONS SUNEVA MEDICAL AS LEADER IN REGENERATIVE AESHTETICS
Suneva Announces the Addition of Two Innovative Products to its Aesthetics Portfolio
January 3, 2019 (San Diego, CA) – Suneva® Medical, Inc., is proud to announce two exciting new partnerships intended to shape the future of regenerative aesthetics. Building on the success of Bellafill, its flagship regenerative biostimulatory product and the longest lasting dermal filler on the market, Suneva Medical has signed two new partnerships with Healeon Medical, Inc and Puregraft, LLC.
“The combination of our world class commercial organization and these unique and innovative Aesthetic products strategically positions us for long term growth as a leader in the regenerative aesthetic market,” says Preston Romm, CEO, Suneva Medical. “These new products will add significant breadth to Suneva’s product portfolio.” Healeon Medical of Newbury Park, California develops and commercializes next generation innovative medical devices and offers clinical expertise, and education to medical professionals in the regenerative medicine market. Healeon has signed a partnership with Suneva Medical for certain markets on their proprietary, cutting-edge PRP technology, featuring an innovative high platelet capture design and a longterm exclusive relationship on Healeon’s next generation technologies arriving to the aesthetics market mid-2019.
“Healeon Medical has a concentration on the growth of regenerative medicine, making Suneva Medical a great partner as it continues to lead this promising area of aesthetics,” says Jeff Greiner, CEO of Healeon Medical.
Based in Solana Beach, California, Puregraft LLC is the world’s leading fat grafting company. In 15 minutes or less, the Puregraft products provide surgeons with purified fat for reinjection. Puregraft is devoted to developing fat based technology focused on the emerging regenerative aesthetics market. Suneva Medical has a distribution partnership with Bimini for certain markets on their proprietary Puregraft fat grafting system for use within the regenerative skin and body care industry and an exclusive relationship on their next generation technology scheduled to launch in early to mid-year 2019.
“Suneva Medical is a seamless connection for our Puregraft products and its next generation technology. We look forward to growing the relationship and working together to shape the global aesthetics market,” says Brad Conlan, CEO of Puregraft.
To learn more about Suneva Medical and upcoming news from the aesthetics company, please visit www.SunevaMedical.com.
About Suneva Medical, Inc.
Suneva Medical is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only dermal filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years old. The company markets Bellafill® in the U.S., Canada, Hong Kong, Korea and Mexico. For more information, visit www.sunevamedical.com.
About Healeon Medical, Inc. Healeon Medical, Inc. (HMI) is a CA-based privately held corporation focused on developing innovative medical devices, clinical expertise and support for point-of-care regenerative treatments. Healeon has rapidly emerged as a major player in the regenerative medicine market with a vertically integrated platform for regenerative medicine therapy. Healeon actively innovates new technologies for tissue acquisition and isolation, with the intent to further simplify the point-of-care process for the enduser. Healeon’s technologies and techniques offer easier and safer solutions that isolate unparalleled cell and protein concentrates designed to meet individual practice and patient’s needs. For more information, visit www.healeonmedical.com
About Puregraft, LLC. Puregraft, LLC is a wholly owned subsidiary of Bimini Technologies, a privately held company focused on the cash-pay, aesthetic marketplace. The Bimini portfolio also includes Kerastem, LLC (www.kerastem.com) and Aurastem, LLC. Today, Bimini’s products are distributed in over 60 countries.